Portfolio company
Cellanome
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
1Cell.Ai
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
Deepcell
Deepcell develops an artificial intelligence-powered imaging and sorting platform for single-cell morphology analysis, serving life sciences researchers, diagnostic labs, and pharmaceutical companies.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
